The solution was a sugar and water solution made four years ago and was used to evaluate patients’ responses to sweets. No one was harmed by the solution, but the NIH is still looking into where the particles in the solution came from.
The solution was prepared in the Pharmaceutical Development Section of the NIH Clinical Center in 2012. That unit of the center was shut down in 2016 after the Food and Drug Administration faulted it for its sterility processes.
The FDA told The Washington Post it is “gathering information to determine if additional action is necessary” in this case.
More articles on patient safety:
5 ICU room design strategies for patient safety
FDA bans powdered gloves: New rule effective January 18
Rounding tools can eliminate medical communication errors, study finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.